Literature DB >> 10773545

Biologically stable [(18)F]-labeled benzylfluoride derivatives.

Y Magata1, L Lang, D O Kiesewetter, E M Jagoda, M A Channing, W C Eckelman.   

Abstract

Use of the [(18)F]-fluoromethyl phenyl group is an attractive alternative to direct fluorination of phenyl groups because the fluorination of the methyl group takes place under milder reaction conditions. However, we have found that 4-FMeBWAY showed femur uptake equal to that of fluoride up to 30 min in rat whereas 4-FMeQNB had a significantly lower percent injected dose per gram in femur up to 120 min. For these and other benzylfluoride derivatives, there was no clear in vivo structure-defluorination relationship. Because benzylchlorides (BzCls) are known alkylating agents, benzylfluorides may be alkylating agents as well, which may be the mechanism of defluorination. On this basis, the effects of substitution on chemical stability were evaluated by the 4-(4-nitro-benzyl)-pyridine (NBP) test, which is used to estimate alkylating activity with NBP. The effect of substitution on the alkylating activity was evaluated for nine BzCl derivatives: BzCl; 3- or 4-methoxy (electron donation) substituted BzCl; 2-, 3-, or 4-nitro (electron withdrawing) substituted BzCl; and 2-, 3-, or 4-chloro (electron withdrawing) substituted BzCl. Taken together, the alkylating reactivity of 3-chloro-BzCl was the weakest. This result was then applied to [(18)F]-benzylfluoride derivatives and in vivo and in vitro stability were evaluated. Consequently, 3-chloro-[(18)F]-benzylfluoride showed a 70-80% decrease of defluorination in both experiments in comparison with [(18)F]-benzylfluoride, as expected. Moreover, a good linear relationship between in vivo femur uptake and in vitro hepatocyte metabolism was observed with seven (18)F-labeled radiopharmaceuticals, which were benzylfluorides, alkylfluorides, and arylfluorides. Apparently, the [(18)F]-fluoride ion is released by metabolism in the liver in vivo. In conclusion, 3-chloro substituted BzCls are the most stable, which suggests that 3-chloro benzylfluorides will be the most chemically stable compound. This result should be important in future design of radioligands labeled with a benzylfluoride moiety.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773545     DOI: 10.1016/s0969-8051(99)00108-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

1.  Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain.

Authors:  H Umesha Shetty; Sami S Zoghbi; Fabrice G Siméon; Jeih-San Liow; Amira K Brown; Pavitra Kannan; Robert B Innis; Victor W Pike
Journal:  J Pharmacol Exp Ther       Date:  2008-09-19       Impact factor: 4.030

2.  The Dark Side of Fluorine.

Authors:  Yue Pan
Journal:  ACS Med Chem Lett       Date:  2019-06-20       Impact factor: 4.345

3.  Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry.

Authors:  Ganesan Vaidyanathan; Benjamin J White; Michael R Zalutsky
Journal:  Curr Radiopharm       Date:  2009-01-01

4.  Ortho-Stabilized (18) F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers.

Authors:  Lu Wang; Orit Jacobson; Din Avdic; Benjamin H Rotstein; Ido D Weiss; Lee Collier; Xiaoyuan Chen; Neil Vasdev; Steven H Liang
Journal:  Angew Chem Int Ed Engl       Date:  2015-08-20       Impact factor: 15.336

5.  Single-step Radiosyntheses of '18F-Labeled Click Synthons' from Azide-functionalized Diaryliodonium Salts.

Authors:  Chun Joong-Hyun; Victor W Pike
Journal:  European J Org Chem       Date:  2012-08-01

Review 6.  Translating a radiolabeled imaging agent to the clinic.

Authors:  Gary L Griffiths; Crystal Vasquez; Freddy Escorcia; Jeff Clanton; Liza Lindenberg; Esther Mena; Peter L Choyke
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

Review 7.  Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals.

Authors:  Brendan J Evans; Andrew T King; Andrew Katsifis; Lidia Matesic; Joanne F Jamie
Journal:  Molecules       Date:  2020-05-14       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.